Agencies | Governor
Virginia Regulatory Town Hall
Department of Health Professions
Board of Pharmacy

General Notice
Scheduling/De-scheduling to conform to Drug Enforcement Administration schedules
Date Posted: 4/25/2018
Expiration Date: 6/7/2018
Submitted to Registrar for publication: YES
No comment forum defined for this notice.

Pursuant to subsection E of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider scheduling or de-scheduling certain drugs in the Virginia Drug Control Act.  The public hearing will be conducted at 9:00 a.m. on June 21, 2018 at the Perimeter Center, 9960 Mayland Drive, Suite 201, Richmond, VA 23233.

 In order to conform the Drug Control Act to recent scheduling changes enacted by the Drug Enforcement Administration, the Board will:

  1. Add MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) to Schedule I;
  2. Add Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration to Schedule II; and
  3. Remove naldemedine from Schedule II.

Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, 23233
Email Address:
Telephone: (804)367-4456    FAX: (804)527-4472    TDD: ()-